Epr Pharmaceuticals Private Limited

Epr Pharmaceuticals Private Limited — pharma in Andhra Pradesh, Telangana, India. FY 2026 financials and compliance.
CIN U24239TG2003PTC040924 Incorporated 30 April 2003 ROC Hyderabad HQ Andhra Pradesh, Telangana, India
Under Liquidation Private Limited Company pharma
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
*****
In full report
Net profit · Latest
*****
In full report
Authorised capital
₹15.5 Cr
Registered with MCA
Paid-up capital
₹4 Cr
Issued & subscribed
Open charges
None
Satisfied ₹2.7 Cr
Company age
23 yrs
Est. 2003
Last financials
Mar 2014
Balance sheet date

About Epr Pharmaceuticals Private Limited

Data last updated: 25 July 2025

Epr Pharmaceuticals Private Limited is a private limited company based in Andhra Pradesh, Telangana, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 30 April 2003, the company has been in operation for over 23 years.

Registered with ROC Hyderabad under CIN U24239TG2003PTC040924.

Capital: an authorised share capital of ₹15.5 Cr and a paid-up capital of ₹4 Cr. It is led by directors including Sirigireddy Reddy and Onteddu Devi Nirmala.

Last AGM: 30 September 2014. Financial statements filed for year ended 31 March 2014. Office: Plot No.557 Road No.31 Jubilee Hills Hyderabad-33., Andhra Pradesh, Telangana, India – 500033.

As per MCA filings, the company has satisfied charges of ₹2.7 Cr on record.

The company is currently under liquidation — its assets are being sold to settle outstanding debts. It may lack the legal capacity to fulfil new agreements, and creditors are prioritised in the distribution of proceeds.

Company Details of Epr Pharmaceuticals Private Limited
CIN U24239TG2003PTC040924
Registration Number 040924
Incorporation Date 30 April 2003
ROC Hyderabad
Listing Status Unlisted
Company Status Under Liquidation
Date of Last AGM 30 September 2014
Date of Balance Sheet 31 March 2014
Key People
Sirigireddy Reddy Additional Director Onteddu Devi Nirmala Director Markandeya Gorantla Additional Director
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Plot No.557 Road No.31 Jubilee Hills Hyderabad-33., Andhra Pradesh, Telangana, India – 500033
  • Industry
    Pharma, Pharma Contract R&D
Company report
Epr Pharmaceuticals Private Limited — full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Epr Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Epr Pharmaceuticals Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Epr Pharmaceuticals Private Limited

Epr Pharmaceuticals Private Limited has one previous CIN (Corporate Identification Number): U24239AP2003PTC040924. The current CIN is U24239TG2003PTC040924, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24239TG2003PTC040924 Current
U24239AP2003PTC040924 Previous

Board of Directors of Epr Pharmaceuticals Private Limited

Epr Pharmaceuticals Private Limited is currently managed by 5 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Directors (as last reported)
Name Designation Appointment Date Tenure Status
Sirigireddy Reddy Additional Director 10 Jul 2015 10 Years 11 Months As last reported
Onteddu Devi Nirmala
Also directs: Npp Bagh-Bagicha Llp
Director 30 Apr 2003 23 Years 2 Months As last reported
Markandeya Gorantla
Also directs: Green Habitat Holdings Llp, Dr Gorantla Llp, Wt Faba Biocatalyst Llp and 5 more
Additional Director 10 Jul 2015 10 Years 11 Months As last reported
Premkumar Eragam Reddy Director 04 Nov 2003 22 Years 8 Months As last reported
Prashanth Eragam Reddy Director 24 Aug 2004 21 Years 10 Months As last reported
View all directors

Financials of Epr Pharmaceuticals Private Limited FY 2014 filings available

Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated — Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Epr Pharmaceuticals Private Limited

Open charges
₹0
Satisfied charges
₹2.7 Cr
Breakdown by lending institutions
Karvy Financial Services Limited₹2.70 Cr
Latest charge details
DateLenderAmountStatus
03 Oct 2011 Karvy Financial Services Limited ₹2.7 Cr Satisfied

Total charge records: 1 View all charges

Employees and EPFO Compliance at Epr Pharmaceuticals Private Limited

View historical data on people associated with Epr Pharmaceuticals Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Epr Pharmaceuticals Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Epr Pharmaceuticals Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Epr Pharmaceuticals Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Epr Pharmaceuticals Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay — Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Epr Pharmaceuticals Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Epr Pharmaceuticals Private Limited

MSME Payment Delays by Epr Pharmaceuticals Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Epr Pharmaceuticals Private Limited

Subsidiaries & Group Companies of Epr Pharmaceuticals Private Limited

See the full corporate group — holding company, subsidiaries, associates and joint ventures of Epr Pharmaceuticals Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Epr Pharmaceuticals Private Limited

MCA Filings & Documents of Epr Pharmaceuticals Private Limited

Download official documents filed with the Ministry of Corporate Affairs — from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Epr Pharmaceuticals Private Limited

Directors
10 Jul 2015
Sirigireddy Reddy was appointed as a Additional Director on 10 Jul 2015 & has been associated with this company since 10 years 11 months.
Directors
10 Jul 2015
Markandeya Gorantla was appointed as a Additional Director on 10 Jul 2015 & has been associated with this company since 10 years 11 months.
Activity
30 Sep 2014
Epr Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2014 as per latest MCA records.
Charges
20 Aug 2014
A charge registered on 03 Oct 2011 via Charge ID 10319904 with Karvy Financial Services Limited was fully satisfied on 20 Aug 2014.
Activity
31 Mar 2014
Epr Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Hyderabad.
Charges
03 Oct 2011
A charge with Karvy Financial Services Limited amounted to Rs. 2.70 Cr with Charge ID 10319904 was registered on 03 Oct 2011.

Frequently Asked Questions about Epr Pharmaceuticals Private Limited

Epr Pharmaceuticals Private Limited is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status — caution is strongly advised.

Epr Pharmaceuticals Private Limited is a company under liquidation, formerly operating as a private limited company in the pharma sector based in Andhra Pradesh, Telangana, India. It was incorporated on 30 April 2003 and is registered under CIN U24239TG2003PTC040924. Caution is advised - the company may not have the legal capacity to fulfil new agreements.

The current directors of Epr Pharmaceuticals Private Limited are:

The CIN (Corporate Identification Number) of Epr Pharmaceuticals Private Limited is U24239TG2003PTC040924. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Epr Pharmaceuticals Private Limited has no open charges and satisfied charges of ₹2.7 Cr as per latest MCA filings.

The primary industry of Epr Pharmaceuticals Private Limited is pharma. The company specifically operates in pharma contract r and d.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding — sourced from MCA, SEBI and RBI filings.

Subscription plans available